Vanda Pharmaceuticals Announces Participation at the Citi 12th Annual Biotech Conference
07 9월 2017 - 6:00AM
PR Newswire (US)
WASHINGTON, Sept. 6, 2017
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:
VNDA) today announced that it will participate at the Citi
12th Annual Biotech Conference. Vanda will host meetings
at the Citi Biotech Conference in Boston on Thursday,
September 7, 2017.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the
development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-the-citi-12th-annual-biotech-conference-300514948.html
SOURCE Vanda Pharmaceuticals Inc.
Copyright 2017 PR Newswire
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
